10.1021/jm701093y 55 HoJ
In January 2024, the FDA proposed a rule that would prevent BPC-157 from being used in compounding, classifying it alongside other peptides that lack adequate safety and efficacy data for compounded use 3
For example, the signal transduction pathway involves 56 target genes, of which 8 are related to target genes, namely 1L1B, AKT1, MAPK1, CREB1, EGFR, CD4, STAT3, and SRC MFs are mainly enriched in protein binding, identical protein binding, ATP binding, protein homodimerization activity, enzyme binding, protein kinase activity, protein serine/threonine kinase activity, zinc ion binding, protein kinase binding, G-protein coupled receptor activity, etc
O BPC-157 e o TB-500 (fragmento da timosina beta-4) so ambos estudados por suas propriedades regenerativas, mas atuam por mecanismos diferentes